Free Trial
→ Elon just did WHAT!? (From Brownstone Research) (Ad) Buy UXIN Stock  Free UXIN Stock Alerts

Uxin (UXIN) Financials

Uxin logo
$4.54 0.00 (0.00%)
Closing price 03:59 PM Eastern
Extended Trading
$4.53 -0.01 (-0.33%)
As of 04:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Uxin

Annual Income Statements for Uxin

This table shows Uxin's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2019 2018 2017 2016
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Net Income / (Loss) Attributable to Common Shareholders		 -337 -130 -23 -64 -286 -347 -579 -255
Consolidated Net Income / (Loss)		 -51 -20 -23 -64 -286 -224 -422 -200
Net Income / (Loss) Continuing Operations		 -53 -21 -23 -109 -191 -197 -195 -200
Total Pre-Tax Income 		-52 -21 -23 -111 -195 -197 -195 -198
Total Operating Income		 -43 -52 -44 -84 -186 -362 -60 -180
Total Gross Profit		 11 3.70 7.53 -2.48 129 35 33 42
Total Revenue		 190 300 258 100 228 96 47 118
Operating Revenue		 190 300 258 100 228 96 47 118
Total Cost of Revenue		 179 296 251 102 99 61 14 76
Operating Cost of Revenue		 179 296 251 102 99 61 14 76
Total Operating Expenses		 54 56 52 82 315 396 93 221
Selling, General & Admin Expense		 25 24 24 42 58 156 60 84
Marketing Expense		 28 34 35 52 170 217 28 114
Research & Development Expense		 4.68 5.49 5.71 11 20 18 0.00 24
Other Operating Expenses / (Income)		 -2.86 -8.18 -13 -24 67 5.27 5.56 -0.28
Total Other Income / (Expense), net		 -8.69 31 21 -27 -9.81 165 -136 -19
Interest Expense		 8.67 3.50 6.50 15 16 9.30 0.03 -
Interest & Investment Income		 0.02 35 30 6.87 0.78 3.57 0.34 0.10
Other Income / (Expense), net		 -0.04 -1.39 -2.06 -20 5.57 171 -136 -19
Income Tax Expense		 0.04 0.05 0.04 0.01 -0.37 0.24 0.03 0.26
Other Gains / (Losses), net		 -0.82 -0.01 0.05 2.38 4.34 0.38 0.55 -1.38
Other Adjustments to Consolidated Net Income / (Loss)		 1.66 1.51 0.00 - - - - -
Preferred Stock Dividends Declared		 285 110 0.00 0.00 - 126 161 60
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.39 -0.00 0.00 -0.00 -0.42 -4.59 -3.87 -5.04
Basic Earnings per Share		 ($0.02) ($0.10) ($0.02) - - - ($46.52) ($36.11)
Weighted Average Basic Shares Outstanding		 2.19B 1.34B 1.17B 1.10B 886.61M 477.85M 49.32M 49.17B
Diluted Earnings per Share		 ($0.02) ($0.10) ($0.33) - - - ($29.99) ($36.11)
Weighted Average Diluted Shares Outstanding		 2.19B 1.34B 1.35B 1.33B 886.61M 477.85M 49.32M 49.17B
Weighted Average Basic & Diluted Shares Outstanding		 56.40B 1.41B 1.19B 1.13B 127.30M 477.85M 49.32M 49.17B

Quarterly Income Statements for Uxin

No quarterly income statements for Uxin are available.

Annual Cash Flow Statements for Uxin

This table details how cash moves in and out of Uxin's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2019 2018 2017 2016
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Net Change in Cash & Equivalents		 -9.61 -6.26 -15 -86 -230 272 134 -112
Net Cash From Operating Activities		 -36 -37 -133 -171 -171 -332 -281 -95
Net Cash From Continuing Operating Activities		 -36 -37 -133 -171 -171 -193 -281 -95
Net Income / (Loss) Continuing Operations		 -51 -20 -23 -64 -286 -224 -422 -200
Consolidated Net Income / (Loss)		 -51 -20 -23 -64 -286 -224 -422 -200
Depreciation Expense		 1.70 1.94 2.25 7.06 13 13 10 7.07
Amortization Expense		 3.96 2.55 2.43 1.68 12 0.82 0.56 0.46
Non-Cash Adjustments To Reconcile Net Income		 11 -33 -25 -22 205 -8.14 2.80 122
Changes in Operating Assets and Liabilities, net		 -2.18 12 -90 -93 -116 25 126 -25
Net Cash From Investing Activities		 -1.57 -4.66 -2.65 67 -70 -157 -90 1.34
Net Cash From Continuing Investing Activities		 -1.57 -4.66 -2.65 67 -70 -157 -90 1.34
Purchase of Property, Plant & Equipment		 -1.76 -4.83 -2.94 -0.06 -6.72 -19 -12 -14
Sale of Property, Plant & Equipment		 0.19 0.07 0.30 2.03 6.26 1.13 0.14 1.65
Divestitures		 0.00 0.10 0.00 65 0.00 0.00 0.00 -
Net Cash From Financing Activities		 28 35 121 20 11 622 505 -19
Net Cash From Continuing Financing Activities		 28 35 121 20 11 622 505 -19
Repayment of Debt		 -2.77 -42 -22 -6.25 -257 0.00 -31 -26
Issuance of Debt		 11 46 0.00 0.00 266 375 123 28
Issuance of Preferred Equity		 20 31 140 0.00 0.00 244 418 23
Other Financing Activities, net		 0.00 0.01 2.48 0.29 1.85 3.73 0.00 0.00
Effect of Exchange Rate Changes		 -0.13 0.03 -0.02 -2.24 0.14 - 0.51 0.93
Cash Interest Paid		 0.36 8.58 0.81 3.00 11 4.67 0.98 0.50
Cash Income Taxes Paid		 0.04 0.03 0.03 0.00 1.11 0.67 0.99 0.04

Quarterly Cash Flow Statements for Uxin

No quarterly cash flow statements for Uxin are available.

Annual Balance Sheets for Uxin

This table presents Uxin's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020 12/31/2019 12/31/2018 12/31/2017
Total Assets		 289 105 197 188 372 773 1,070 813
Total Current Assets		 31 41 138 127 314 710 971 752
Cash & Equivalents		 3.23 14 20 29 48 69 117 45
Restricted Cash		 0.08 0.09 1.31 6.25 64 102 147 248
Note & Lease Receivable		 0.00 0.00 8.66 27 59 227 81 106
Accounts Receivable		 2.79 2.35 26 37 45 77 110 138
Inventories, net		 15 16 67 11 1.45 1.98 2.82 12
Prepaid Expenses		 9.94 8.94 14 16 19 23 61 38
Plant, Property, & Equipment, net		 10 9.28 5.45 4.46 12 16 29 24
Total Noncurrent Assets		 248 54 54 56 45 47 70 37
Long-Term Investments		 39 42 46 44 39 39 51 24
Noncurrent Note & Lease Receivables		 186 0.00 - - - - - -
Other Noncurrent Operating Assets		 23 12 8.45 13 4.84 6.52 0.00 -
Total Liabilities & Shareholders' Equity		 289 105 197 188 372 773 1,070 813
Total Liabilities		 309 189 353 491 701 706 725 776
Total Current Liabilities		 123 88 205 174 432 430 651 666
Short-Term Debt		 51 26 37 12 69 84 264 65
Accounts Payable		 11 12 15 26 19 18 23 10
Accrued Expenses		 51 49 106 136 165 187 164 142
Other Current Liabilities		 8.79 1.12 47 0.37 136 67 67 409
Total Noncurrent Liabilities		 186 101 148 317 269 276 74 110
Long-Term Debt		 0.00 81 129 281 269 275 70 57
Other Noncurrent Operating Liabilities		 186 20 19 36 0.26 1.48 2.82 53
Commitments & Contingencies		 0.00 0.00 0.00 0.00 - - - 0.00
Redeemable Noncontrolling Interest		 21 101 83 0.00 - - - 1,292
Total Equity & Noncontrolling Interests		 -41 -185 -238 -304 -329 67 345 -1,255
Total Preferred & Common Equity		 -41 -185 -238 -304 -329 67 346 -1,248
Preferred Stock		 0.00 - - - - - - -
Total Common Equity		 -41 -185 -238 -304 -329 67 346 -1,248
Common Stock		 2,627 2,250 2,249 2,083 1,830 1,877 1,888 0.00
Retained Earnings		 -2,684 -2,468 -2,532 -2,420 -2,175 -1,819 -1,555 -1,259
Accumulated Other Comprehensive Income / (Loss)		 31 32 46 33 15 9.79 13 12
Other Equity Adjustments		 -15 - 0.00 - - - - -
Noncontrolling Interest		 -0.03 -0.03 -0.03 -0.02 -0.02 -0.58 -0.36 -7.74

Quarterly Balance Sheets for Uxin

No quarterly balance sheets for Uxin are available.

Annual Metrics And Ratios for Uxin

This table displays calculated financial ratios and metrics derived from Uxin's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 12/31/2019 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Growth Metrics		 - - - - - - - - -
Revenue Growth		 -36.50% 16.18% 158.11% 0.00% 137.67% 137.67% 102.24% -59.88% 0.00%
EBITDA Growth		 22.91% -18.10% 56.43% 38.85% 12.48% 12.48% 3.83% 3.23% 0.00%
EBIT Growth		 18.80% -15.85% 55.59% 42.37% 5.87% 5.87% 2.23% 1.34% 0.00%
NOPAT Growth		 16.72% -18.11% 47.65% 54.69% 48.78% 48.78% -507.99% 66.81% 0.00%
Net Income Growth		 -156.25% 11.59% 64.74% 0.00% -27.62% -27.62% 46.90% -111.10% 0.00%
EPS Growth		 78.36% 11.59% 0.00% 0.00% -89.61% 0.00% 0.00% 16.95% 0.00%
Operating Cash Flow Growth		 0.60% 72.56% 21.92% 0.00% 48.37% 48.37% -17.98% -196.86% 0.00%
Free Cash Flow Firm Growth		 12.81% 6.43% 30.74% -145.74% 110.65% 69.73% -599.65% 0.00% 0.00%
Invested Capital Growth		 67.73% 42.09% 37.22% 27.41% -313.66% 26.92% 205.64% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 5.86% 1.24% 2.92% -2.48% 56.59% 56.59% 36.45% 70.00% 35.31%
EBITDA Margin		 -19.79% -16.30% -16.03% -94.97% -68.11% -68.11% -184.95% -388.95% -161.27%
Operating Margin		 -22.73% -17.33% -17.05% -84.06% -81.37% -81.37% -377.56% -125.59% -151.84%
EBIT Margin		 -22.76% -17.80% -17.85% -103.71% -78.92% -78.92% -199.28% -412.20% -167.64%
Profit (Net Income) Margin		 -26.88% -6.66% -8.75% -64.07% -125.32% -125.32% -233.40% -888.87% -168.94%
Tax Burden Percent		 98.48% 93.23% 99.94% 57.50% 292.57% 146.28% 113.72% 215.99% 100.83%
Interest Burden Percent		 119.96% 40.15% 49.08% 107.45% 217.10% 108.55% 102.99% 99.84% 99.95%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% -305.90% -68.97% -5,723.02% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% -758.42% 812.10% -5,738.91% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% -3,261.87% -69.75% 5,605.75% 0.00% 0.00%
Return on Equity (ROE)		 98.47% 16.69% 9.85% 20.25% -3,349.98% -138.71% -117.26% -1,149.61% 0.00%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -92.69% -347.43% 0.00% 0.00%
Operating Return on Assets (OROA)		 -22.00% -35.34% -23.93% -37.08% -24.97% -19.53% -20.31% -24.05% 0.00%
Return on Assets (ROA)		 -25.99% -13.23% -11.74% -22.91% -39.65% -31.01% -23.78% -51.86% 0.00%
Return on Common Equity (ROCE)		 214.05% 29.55% 11.63% 20.25% -3,436.02% -139.03% 277.02% 39,108.64% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 126.19% 10.77% 9.49% 21.11% 86.81% -424.18% -64.79% 33.79% 0.00%
Net Operating Profit after Tax (NOPAT)		 -30 -36 -31 -59 -130 -130 -254 -42 -126
NOPAT Margin		 -15.91% -12.13% -11.93% -58.84% -56.96% -56.96% -264.29% -87.91% -106.29%
Net Nonoperating Expense Percent (NNEP)		 68.82% -21.86% -5.26% 2.50% 905.05% -881.07% 15.89% -392.14% 0.00%
Cost of Revenue to Revenue		 94.14% 98.76% 97.08% 102.48% 43.41% 43.41% 63.55% 30.00% 64.69%
SG&A Expenses to Revenue		 12.90% 7.99% 9.23% 42.28% 25.32% 25.32% 162.41% 125.86% 70.79%
R&D to Revenue		 2.46% 1.83% 2.21% 11.28% 8.82% 8.82% 18.89% 0.00% 20.35%
Operating Expenses to Revenue		 28.59% 18.57% 19.97% 81.58% 137.96% 137.96% 412.67% 195.59% 187.15%
Earnings before Interest and Taxes (EBIT)		 -43 -53 -46 -104 -180 -180 -191 -196 -198
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -38 -49 -41 -95 -155 -155 -177 -184 -191
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 9.85 35.16 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 10.06 37.22 0.00 0.00
Price to Revenue (P/Rev)		 0.52 0.30 1.48 3.53 1.26 2.91 126.65 4.74 1.90
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% -99.25% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 3.78 72.54 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.68 0.81 2.19 5.66 2.07 3.49 125.50 27.73 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 2.33 0.00 0.00 11.40 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 -2.59 -1.27 -1.07 -0.97 -2.05 5.38 0.97 3.35 0.00
Long-Term Debt to Equity		 0.00 -0.96 -0.83 -0.93 -1.63 4.11 0.20 1.57 0.00
Financial Leverage		 -0.58 -0.63 -0.68 -0.66 8.60 -0.09 -0.98 -5.28 0.00
Leverage Ratio		 -3.79 -1.26 -0.84 -0.88 179.98 4.47 4.93 22.17 0.00
Compound Leverage Factor		 -4.54 -0.51 -0.41 -0.95 195.36 4.86 5.08 22.13 0.00
Debt to Total Capital		 163.02% 466.98% 1,566.99% -2,781.89% 7,574.73% 84.32% 49.17% 77.02% 0.00%
Short-Term Debt to Total Capital		 163.02% 113.52% 347.51% -114.88% 1,555.43% 19.82% 38.85% 41.04% 0.00%
Long-Term Debt to Total Capital		 0.00% 353.46% 1,219.48% -2,667.01% 6,019.30% 64.50% 10.33% 35.97% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 65.96% 441.72% 784.98% 0.24% -0.24% -0.14% -0.05% 804.90% 0.00%
Common Equity to Total Capital		 -128.99% -808.69% -2,251.97% 2,881.66% -3,687.12% 15.81% 50.88% -781.91% 0.00%
Debt to EBITDA		 -1.36 -2.19 -4.01 -3.09 -2.18 -2.31 -1.88 -0.67 0.00
Net Debt to EBITDA		 -0.25 -1.05 -2.38 -2.25 -1.19 -0.85 0.62 1.05 0.00
Long-Term Debt to EBITDA		 0.00 -1.66 -3.12 -2.96 -1.73 -1.77 -0.40 -0.31 0.00
Debt to NOPAT		 -1.69 -2.94 -5.38 -4.98 -2.60 -2.77 -1.32 -2.95 0.00
Net Debt to NOPAT		 -0.31 -1.41 -3.20 -3.63 -2.85 -1.02 0.44 4.65 0.00
Long-Term Debt to NOPAT		 0.00 -2.23 -4.19 -4.77 -2.07 -2.12 -0.28 -1.38 0.00
Altman Z-Score		 -13.01 -32.09 -17.18 -19.22 -9.31 -2.77 7.89 -2.60 0.00
Noncontrolling Interest Sharing Ratio		 -117.37% -77.02% -18.09% 0.01% -2.17% -0.23% 336.24% 3,501.89% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.26 0.47 0.67 0.73 1.46 1.65 1.49 1.13 0.00
Quick Ratio		 0.05 0.18 0.27 0.54 0.70 0.91 0.67 0.43 0.00
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -52 -60 -64 -93 203 -175 -577 115 0.00
Operating Cash Flow to CapEx		 -2,314.54% -767.97% -5,038.83% 0.00% -74,422.03% -37,211.02% -1,808.11% -2,283.50% -792.42%
Free Cash Flow to Firm to Interest Expense		 -6.05 -17.20 -9.89 -6.36 12.55 -10.80 -62.01 3,779.14 0.00
Operating Cash Flow to Interest Expense		 -4.19 -10.46 -20.50 -11.70 -21.21 -10.61 -35.71 -9,217.16 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -4.37 -11.82 -20.90 -11.56 -10.63 -10.63 -37.69 -9,620.80 0.00
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.97 1.99 1.34 0.36 0.32 0.25 0.10 0.06 0.00
Accounts Receivable Turnover		 74.04 20.92 8.18 2.44 2.93 2.43 0.77 0.34 0.00
Inventory Turnover		 11.40 7.10 6.44 17.03 46.37 41.23 8.25 1.19 0.00
Fixed Asset Turnover		 19.47 40.72 52.12 11.94 11.04 10.18 3.62 1.97 0.00
Accounts Payable Turnover		 15.63 22.48 12.36 4.60 4.79 4.82 3.71 1.41 0.00
Days Sales Outstanding (DSO)		 4.93 17.45 44.62 149.71 124.64 150.05 472.92 1,062.76 0.00
Days Inventory Outstanding (DIO)		 32.02 51.39 56.68 21.43 7.87 8.85 44.25 306.77 0.00
Days Payable Outstanding (DPO)		 23.35 16.23 29.54 79.32 76.22 75.80 98.29 258.57 0.00
Cash Conversion Cycle (CCC)		 13.61 52.60 71.77 91.82 56.29 83.10 418.88 1,110.97 0.00
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 -11 -33 -56 -90 -124 211 166 -157 0.00
Invested Capital Turnover		 -8.80 -6.72 -3.53 -0.94 5.37 1.21 21.65 -0.60 0.00
Increase / (Decrease) in Invested Capital		 22 24 33 34 -333 45 323 -157 0.00
Enterprise Value (EV)		 130 242 564 566 473 795 12,039 1,316 0.00
Market Capitalization		 100 89 383 353 288 663 12,150 225 225
Book Value per Share		 ($0.03) ($0.16) ($0.21) ($0.34) ($2.59) $0.08 $0.72 ($25.30) $0.00
Tangible Book Value per Share		 ($0.03) ($0.16) ($0.21) ($0.34) ($2.60) $0.07 $0.68 ($25.57) $0.00
Total Capital		 31 23 11 -11 8.93 426 679 160 0.00
Total Debt		 51 107 166 293 338 359 334 123 0.00
Total Long-Term Debt		 0.00 81 129 281 269 275 70 57 0.00
Net Debt		 9.27 51 99 214 185 132 -110 -194 0.00
Capital Expenditures (CapEx)		 1.57 4.76 2.65 -1.97 0.46 0.46 18 12 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -43 -34 -52 -71 -162 177 190 -141 0.00
Debt-free Net Working Capital (DFNWC)		 -40 -21 -30 -36 -48 365 584 152 0.00
Net Working Capital (NWC)		 -91 -47 -67 -48 -118 280 320 86 0.00
Net Nonoperating Expense (NNE)		 21 -16 -8.21 5.23 156 156 -30 380 74
Net Nonoperating Obligations (NNO)		 9.27 51 99 214 205 144 -179 -194 0.00
Total Depreciation and Amortization (D&A)		 5.65 4.49 4.68 8.74 25 25 14 11 7.53
Debt-free, Cash-free Net Working Capital to Revenue		 -22.74% -11.50% -20.02% -71.25% -71.15% 77.59% 198.20% -297.86% 0.00%
Debt-free Net Working Capital to Revenue		 -21.00% -6.97% -11.69% -35.70% -21.12% 159.89% 608.35% 320.07% 0.00%
Net Working Capital to Revenue		 -47.92% -15.64% -25.93% -47.80% -51.57% 122.86% 333.31% 182.01% 0.00%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.02) $0.00 $0.00 $0.00 ($0.22) ($21.00) ($73.00) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 2.19B 134.45M 11.68M 11.01M 127.30M 1.27M 8.81M 0.00 0.00
Adjusted Diluted Earnings per Share		 ($0.02) $0.00 $0.00 $0.00 ($0.11) ($11.00) ($73.00) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 2.19B 134.45M 13.55M 13.31M 127.30M 1.27M 8.81M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 56.40B 141.23M 11.92M 11.25M 127.30M 8.87M 4.78M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -30 -36 -31 -59 -130 -130 -254 -42 -126
Normalized NOPAT Margin		 -15.91% -12.13% -11.93% -58.84% -56.96% -56.96% -264.29% -87.91% -106.29%
Pre Tax Income Margin		 -27.30% -7.15% -8.76% -111.44% -85.67% -85.67% -205.24% -411.54% -167.55%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 -5.00 -15.26 -7.08 -7.11 -22.26 -11.13 -20.56 -6,403.14 0.00
NOPAT to Interest Expense		 -3.49 -10.40 -4.74 -4.03 -16.07 -8.03 -27.27 -1,365.64 0.00
EBIT Less CapEx to Interest Expense		 -5.18 -16.62 -7.49 -6.97 -22.32 -11.16 -22.54 -6,806.78 0.00
NOPAT Less CapEx to Interest Expense		 -3.68 -11.76 -5.14 -3.90 -16.12 -8.06 -29.24 -1,769.28 0.00
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1.06% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1.06% -21.97%

Quarterly Metrics And Ratios for Uxin

No quarterly metrics and ratios for Uxin are available.

Frequently Asked Questions About Uxin's Financials

When does Uxin's fiscal year end?

According to the most recent income statement we have on file, Uxin's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has Uxin's net income changed over the last 7 years?

Uxin's net income appears to be on a downward trend, with a most recent value of -$51.18 million in 2024, falling from -$199.73 million in 2016. The previous period was -$19.97 million in 2023.

What is Uxin's operating income?
Uxin's total operating income in 2024 was -$43.28 million, based on the following breakdown:
  • Total Gross Profit: $11.16 million
  • Total Operating Expenses: $54.44 million
How has Uxin revenue changed over the last 7 years?

Over the last 7 years, Uxin's total revenue changed from $118.22 million in 2016 to $190.40 million in 2024, a change of 61.0%.

How much debt does Uxin have?

Uxin's total liabilities were at $309.02 million at the end of 2024, a 63.7% increase from 2023, and a 60.2% decrease since 2017.

How much cash does Uxin have?

In the past 7 years, Uxin's cash and equivalents has ranged from $3.23 million in 2024 to $116.59 million in 2018, and is currently $3.23 million as of their latest financial filing in 2024.

How has Uxin's book value per share changed over the last 8 years?

Over the last 8 years, Uxin's book value per share changed from 0.00 in 2016 to -0.03 in 2024, a change of -2.9%.


Related Companies

This page (NASDAQ:UXIN) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Elon Set to Shock the World on June 1st?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
Man who predicted $100K Bitcoin sees a huge run coming for another coin …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...
Weiss Ratings | Sponsored
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...
Stansberry Research | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored